Archive

Post Archive: Clinical Trials and Research

Virginia Cancer Specialists » VCS Practice News » Clinical Trials and Research » Page 3

Dr. Alex Spira quoted in announcement from Mirati Theraputics: Progress Of Lead Programs And Updated Positive Clinical Trial Results For Immuno-Oncology Combination Trials

Alex Spira MD PhD FACP, Immunotherapy, Clinical Trials and Research
April 26, 2018
Read More

Virginia Cancer Specialists first patient successfully completes Cycle 1 of Treatment with PCM-075 combination with Low Dose Cytarabine (LDAC) AML Trial

The Research Institute, Alex Spira MD PhD FACP, Clinical Trials and Research, Leukemia
March 6, 2018
Read More

Patient Safety for Clinical Trials is important, here are four questions to ask

The Research Institute, Clinical Trials and Research, Videos
February 7, 2018
Read More

Virginia Cancer Specialists enrolls fist patient in Phase 1b/2 Clinical Trial of PCM-075 for Acute Myeloid Leukemia (AML)

Clinical Trials Search, The Research Institute, Alex Spira MD PhD FACP, Clinical Trials and Research, Leukemia
February 7, 2018
Read More

Two promising new Drugs are available in a Clinical Trial Offered by Virginia Cancer Specialists

The Research Institute, Clinical Trials and Research, Lung Cancer
September 26, 2017
Read More

Immunotherapy Cancer Treatment - Exciting new area for oncology

The Research Institute, Immunotherapy, Clinical Trials and Research
August 29, 2016
Read More

Virginia Cancer Specialists Receives Clinical Trials Research Award from Conquer Cancer Foundation

Clinical Trials and Research
July 12, 2016
Read More
Return to Top